CRISPR Therapeutics AG
CRISPR Therapeutics AG (CRSP) has a dated report snapshot, but its current priced-in claim is temporarily suppressed because the live engine record is unavailable or has changed.
474 institutional managers reported holding CRSP in 13F filings for the quarter ended 2026-03-31. Together they hold about 80% of the company; the top 10 hold 49%. 66 opened new positions that quarter. Held by ARK Investment Management, BlackRock, Capital Group (American Funds), among others. On the short side, 26.6M shares were sold short as of the 2026-06-15 count, about 28% of shares outstanding (16.4 days of typical volume to cover).
Quarterly 13F filings arrive up to 45 days after quarter end, so the picture is never current (filed through 2026-05-29). Nothing here is investment advice.
CRSP's share count grew 26.7% over the past five years. It pays no dividend.
Share counts are split-adjusted; repurchase totals are gross of share issuance. Nothing here is investment advice.
Open-market insider buys at CRSP over the trailing three years: 2025: 6 buys totaling $53.00M. 8 officers and directors are on file.
Code P open-market purchases from SEC Form 4 filings, non-derivative, excluding scheduled 10b5-1 plans. Nothing here is investment advice.
CRSP's recent reports: the day-one move, then what the following quarter actually did.
| report | day one | next quarter |
|---|---|---|
| 2023-08-08 | +4.1% | -17.4% |
| 2023-11-07 | +14.9% | +6.9% |
| 2024-02-22 | +9.5% | -37.7% |
| 2024-05-09 | -3.6% | +6.1% |
Day-one is the close-to-close move around the filing. Nothing here is investment advice.
CRSP's latest 8-K filings: 2026-06-04 (items 5.02, 5.03, 5.07, 9.01); 2026-05-04 (items 2.02, 9.01); 2026-03-16 (items 1.01, 2.03, 3.02, 9.01); 2026-03-11 (items 8.01, 9.01); 2026-02-12 (items 2.02, 9.01).
Item codes are the SEC's own classification of what each report discloses. Nothing here is investment advice.
Last analyzed: June 27, 2026
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.